Navigation Links
FDA Approves New Mechanism of Action Labeling for Ranexa(R)
Date:12/18/2007

PALO ALTO, Calif., Dec. 18 /PRNewswire-FirstCall/ -- CV Therapeutics, Inc. (Nasdaq: CVTX) announced today that the U.S. Food and Drug Administration (FDA) has approved new language for the product labeling for Ranexa(R) (ranolazine extended-release tablets) which describes the ability of ranolazine to inhibit the late sodium current at therapeutic levels.

Published data on ranolazine's mechanism suggests that during ischemic episodes excess sodium can flow into cardiac cells through sodium channels. This excess sodium can trigger a subsequent overload of calcium that can lead to problems with proper contraction and relaxation of the heart. Late sodium current inhibition has been shown to improve mechanical and electrical dysfunctions of cardiac cells under these circumstances.

"We believe it is important for physicians to have as much information as possible on the mechanism of action for Ranexa and we are very pleased that the FDA has worked with us to add this new language to the approved product labeling," said Louis G. Lange, CV Therapeutics chairman and chief executive officer.

Ranexa is currently indicated for the treatment of chronic angina in patients who have not achieved an adequate response with other antianginal drugs, and should be used in combination with amlodipine, beta-blockers or nitrates. Complete product labeling is available at http://www.cvt.com.

About CV Therapeutics

CV Therapeutics, Inc., headquartered in Palo Alto, California, is a biopharmaceutical company focused on applying molecular cardiology to the discovery, development and commercialization of novel, small molecule drugs for the treatment of cardiovascular diseases.

CV
'/>"/>

SOURCE CV Therapeutics, Inc.
Copyright©2007 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2

Related biology technology :

1. Brazilian National Biosafety Technical Committee Approves Monsanto Company Insect-Protected Corn Trait
2. FDA Approves RISPERDAL(R) to Treat Adolescents with Schizophrenia and Children and Adolescents with Bipolar Mania
3. FDA Approves ACAM2000(TM) Vaccine for Protection Against Smallpox
4. NJ Board of Pharmacy Approves Wedgewood Pharmacy Technician-Training Program
5. FDA Approves Expanded Labeling for Campath(R) to Include First-line Treatment for Leading Form of Adult Leukemia
6. FDA Approves New 300mg Loading Dose Tablet for PLAVIX(R) (clopidogrel bisulfate)
7. FDA Approves Administration of LEXIVA(R) with Lower Dose of Boosting Medication Ritonavir
8. FDA Approves DORIBAX(TM) for the Treatment of Complicated Intra-Abdominal and Complicated Urinary Tract Infections
9. FDA Approves IXEMPRA(TM) (ixabepilone), a Semi-Synthetic Analog of Epothilone B, for the Treatment of Advanced Breast Cancer
10. FDA Approves Genzymes Renvela(TM) for Dialysis Patients
11. FDA Approves New SPRYCEL(R) (Dasatinib) Product Labeling for Patients with Chronic-Phase CML
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/10/2008)...tCall/ -- Wyeth (NYSE: WYE ),announced today that...ly,and as Administrator of the Estate of Edna Faye...mmon Pleas found in favor of Wyeth., "We believe ...ce," says,Bob Nicholas, an attorney from Reed Smit...ath was tragic, the medical evidence clearly demon...
(Date:10/10/2008)...e/ -- Finesse Solutions, LLC, a,manufacturer of me...rocess,applications, is pleased to announce improv...ng for sensors and transmitters even easier. The E...://www.finesse.com/shopfinesse ).,Customers can no...es,on-line, anywhere in the world, and at any time...
(Date:10/10/2008)...Twenty of Britain,s most,innovative technology com...s at the fifth annual SETsquared Partnership Showc...at George Street, London, from 8am on,Thursday, Oc...y innovators,in electronics, information technolog...will give 10-minute presentations to an audience o...
(Date:10/9/2008)...wire-FirstCall/ --, - Ranked Number 7 out of top ... Serono, a division of Merck KGaA, Darmstadt, Germ...ence magazine as a top employer in the,biotechnolo... out of the,top 20 employers across the life scien...ty has recognized Merck,Serono as a leading place ...
Breaking Biology Technology:Creators of Britain's Innovation Economy to Showcase the Technologies of the Future at the Fifth SETsquared Partnership Showcase 2008 2Creators of Britain's Innovation Economy to Showcase the Technologies of the Future at the Fifth SETsquared Partnership Showcase 2008 3Merck Serono Named as a Top Employer by Science Magazine 2
... , , , , , , For total ..., , , , , , , ... , RNeasy Protect ... , , , ..., , RNeasy Protect...
... , , , , , , Optimized ... 293, and CHO cells , , Features a...cols for COS-7, NIH/3T3, HeLa, 293, and CHO cells ... No removal of transfection complexes requi...rum , High efficiency, Economi...
... , , , , , , For purifi...d or cosmid DNA , , Features and b... plasmid DNA , Yields of up to 10 mg pl...f plasmid DNA , Fast and simple procedu... * Actual yields depend on plasmid copy number, s...
... , , , , , , High-quali...s efficient , gene silencing in eukaryotic ... , mRNA. This effect, termed RNA interferen...g in functional genomics studies. Now, QIAGEN offe...is service that includes a range of modifications ...
Other Biology Technology:RNeasy Mini, Midi, and Maxi Kits 2RNeasy Mini, Midi, and Maxi Kits 3RNeasy Mini, Midi, and Maxi Kits 4PolyFect Transfection Reagent 2PolyFect Transfection Reagent 3PolyFect Transfection Reagent 4EndoFree Plasmid Kits 2EndoFree Plasmid Kits 3EndoFree Plasmid Kits 4Custom and library siRNA for efficient gene silencing 2Custom and library siRNA for efficient gene silencing 3Custom and library siRNA for efficient gene silencing 4
(Date:10/10/2008)...asterosteus aculeatus , is one of the most thoroug...particularly useful model for understanding variat...hology caused by different ecological situations i...r and genetic to developmental and morphological, ...as proven far more complex than even imagined. , ...
(Date:10/10/2008)... German . , DNA, the molecule that acts as the...fe, is highly resistant against alteration by ultr... its photostability presents some puzzling problem...r chemical bases that make up the DNA molecule. Re...wing that DNA strands differ in their light sensit...
(Date:10/9/2008)...wswire-FirstCall/ -- Aware, Inc. (Nasdaq:,AWRE), a...etrics software,has scheduled a conference call t...third quarter of 2008 on Thursday, October 23, 200...and CFO Rick Moberg will host the,earnings confere...and can be accessed on the,Investor Relations page...
(Date:10/9/2008)...you have to worry about hungry starfish and even h... can change your body temperature 50 degrees Fahre...st variable habitats on Earth," said USC biologist... bathed in cool Pacific seawater and the other par...the first real-time molecular sampling of mussels ...
Breaking Biology News(10 mins):Fitness in a changing world 2Fitness in a changing world 3Can genetic information be controlled by light? 2Aware Announces Q3 2008 Earnings Conference Call 2Brainy genes, not brawn, key to success on mussel beach 2Brainy genes, not brawn, key to success on mussel beach 3HealthSouth To Acquire Rehabilitation Unit at Medical Center of Arlington 23367 1HealthSouth To Acquire Rehabilitation Unit at Medical Center of Arlington 23367 2HealthSouth To Acquire Rehabilitation Unit at Medical Center of Arlington 23367 3Can recycling be used to treat cancer 3F 23363 1Can recycling be used to treat cancer 3F 23363 2BBVA Foundation Awards for Biodiversity Conservation 3917 1BBVA Foundation Awards for Biodiversity Conservation 3917 2BBVA Foundation Awards for Biodiversity Conservation 3917 3BBVA Foundation Awards for Biodiversity Conservation 3917 4E prescribing of Controlled Substances Moves Real Time Prescription Drug Monitoring Toward Reality 23356 1E prescribing of Controlled Substances Moves Real Time Prescription Drug Monitoring Toward Reality 23356 2
...he fascinating interactions between flowers and th...ersity of plants. In order to entice pollinators s...cessfully pollinate their flowers, plants have evo...ch nectar is best known. , Thirty years ago, rese...ted by butterflies contain substantial amounts of ...
...lephants learn to imitate sounds that are not typi...r humans of vocal learning in a non-primate terres...ature, further supports the idea that vocal learni...relationships among animals that separate and reun...s, and bats. , Researchers from the Amboseli Trust...
...cientists at the University of Cincinnati (UC) Col...adly type of secondary stroke known as cerebral va...the brain, cerebral vasospasm usually occurs three...as hemorrhagic stroke. Sixty percent of patients w...nd 40 percent of them die from it. , Vasospasm, s...
...or all its promise, the prospect of using nanopart...ucts has raised concerns about possible harmful ef...e University of Michigan are addressing those conc...ticles damage cell membranes—enough to cause cell ...ented. , "If you,re inventing these sorts of mater...
Other Biology News:Elephants imitate sounds as a form of social communication 2Researchers discover molecule that causes secondary stroke 2Probing The Promise And Perils Of Nanoparticles 2Probing The Promise And Perils Of Nanoparticles 3
Benchtop Laminar Hood (Universal Hood) from Terra Universal, Inc.
...l solutions is the 6890N network gas chromatograph...to share business and scientific data across sites...ts 6890 GC predecessors, this GC has all the flexi...hod development in any industry. It is also rugged...
...nfusion kits reduce the time and expense of prepar...equipment to reduce the risk of infection. Each ki...luding swivel, tubing, tether and connectors. Tubi...u specify, preassembled in Instech's clean room, i...
...or-Activated Receptor-gamma (PPARGamma) Competitor...od for studying and screening potential PPARGamma ...kit contains human PPARGamma-Ligand binding domain...novel, selective fluorescent PPARGamma ligand: Flu...
Biology Products: